Altimmune to Participate in the H.C. Wainwright 8th Annual MASH Virtual Conference

Rhea-AI Summary

Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, has announced its participation in the H.C. Wainwright 8th Annual MASH Virtual Conference. The company's Chief Executive Officer, Vipin Garg, Ph.D., and Chief Medical Officer, Scott Harris, M.D., will take part in a fireside chat during the event.

The presentation is scheduled for Monday, October 7, 2024, at 11:30 a.m. EDT. Interested parties can access the webcast of the session by visiting the Events section of the Altimmune website. This participation provides an opportunity for the company to share insights and updates with investors and industry professionals in a virtual setting.

GAITHERSBURG, Md., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that its Chief Executive Officer, Vipin Garg, Ph.D., and Chief Medical Officer, Scott Harris, M.D., will participate in a fireside chat at the H.C. Wainwright 8^th Annual MASH Virtual Conference:

Conference:	H.C. Wainwright 8thAnnual MASH Virtual Conference
Presenters:	Vipin Garg, Ph.D., Chief Executive Officer
	Scott Harris, M.D., Chief Medical Officer
Date/Time:	Monday, October 7, 2024, at 11:30 a.m. EDT

The session will be webcast and can be accessed by visiting the Events section of the Altimmune website.

About Altimmune

Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH). For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Company Contact:
Vipin Garg
President and Chief Executive Officer
Phone: 240-654-1450
ir@altimmune.com

Media Contact:
Danielle Cantey
Inizio Evoke, Biotech
Phone: 619-826-4657
Danielle.cantey@inizioevoke.com

Investor Contact:
Lee Roth
Burns McClellan
Phone: 646-382-3403
lroth@burnsmc.com

Julia Weilman
Burns McClellan
Phone: 646-732-4443
jweilman@burnsmc.com

This press release was published by a CLEAR® Verified individual.

FAQ

When is Altimmune (ALT) participating in the H.C. Wainwright MASH Virtual Conference?

Altimmune (ALT) is participating in the H.C. Wainwright 8th Annual MASH Virtual Conference on Monday, October 7, 2024, at 11:30 a.m. EDT.

Who will represent Altimmune (ALT) at the H.C. Wainwright conference?

Altimmune (ALT) will be represented by Chief Executive Officer Vipin Garg, Ph.D., and Chief Medical Officer Scott Harris, M.D., at the H.C. Wainwright conference.

How can investors access Altimmune's (ALT) presentation at the H.C. Wainwright conference?

Investors can access the webcast of Altimmune's (ALT) presentation by visiting the Events section of the Altimmune website.

What type of session will Altimmune (ALT) participate in at the H.C. Wainwright conference?

Altimmune (ALT) will participate in a fireside chat at the H.C. Wainwright 8th Annual MASH Virtual Conference.